Racial and Ethnic Disparities in Salivary Gland Cancer Survival

Importance Several recent US studies have documented racial disparities in head and neck cancer outcomes, but few have investigated racial and ethnic differences in salivary gland cancer (SGCA) survival. Objective To determine whether patient race or ethnicity affects SGCA survival. Design, Setting, and Participants Retrospective survival analysis of all patients with SGCA from 1988 through 2010 in the Surveillance, Epidemiology, and End Results database. Main Outcomes and Measures Disease-specific survival according to race and ethnicity. End points assessed included age at diagnosis, sex, tumor grade, tumor size at diagnosis, extension at diagnosis, lymph node involvement at diagnosis, and treatment. Results were further analyzed by histologic subtype of SGCA. Results Of 11 007 patients with SGCA, 1073 (9.7%) were black, and 1068 (9.7%), Hispanic. Whites’ mean age at diagnosis was 63 years vs 53 and 52 years for blacks and Hispanics, respectively ( P P  = .03) but not for Hispanics (HR, 0.97 [0.79-1.19]; P  = .77). The overall disease-specific survival disparity was due to poorer disease-specific survival for blacks vs whites with mucoepidermoid ( P  = .03) and squamous cell carcinomas ( P  = .05). Less surgical treatment for blacks than whites (57.26% vs 76.94%; P Conclusions and Relevance Black race is a risk factor for poorer disease-specific survival for patients with mucoepidermoid or squamous cell carcinoma, whereas Hispanic ethnicity has no effect. Differing treatment between black and white patients affects survival in squamous cell but not mucoepidermoid SGCA. Differences in chemotherapy treatment, comorbidities, socioeconomic status, tumor genetic factors, and environmental exposures are potential but unproven additional sources of the racial survival disparities for mucoepidermoid and squamous cell SGCA.